An outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to discuss a new Alzheimer’s drug from Eli Lilly, the company said Tuesday. The panel will meet June 10, three months after FDA said it wanted advisers to scrutinize the safety and effectiveness of the drug, called donanemab. ...
Michael Bolton had strange symptoms before brain cancer diagnosis: ‘Something’s wrong’
- yesterday, 1:50 PM
- foxnews.com
- 0
No comments